Note: Live price is not available for this stock. Showing closing price. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
LYKALABS Stock Analysis
Views
Red Flags
Positive
Low and declining Debt to Equity
Negative
Expensive and at a premium to industry median P/E
Weak price momentum
Low but stable ROE
Low and declining operating margin
Low revenue growth and lower than median growth of industry
Low EPS growth and lower than median growth of industry
Low dividend yield
Neutral
Company's earnings are of moderate quality
Thinly traded (low daily turnover)
The stock is thinly traded with combined (NSE & BSE) daily turnover (21-day average) of 0.205485.
Snapshot
See detailed analysis
LYKALABS Shareholding Pattern
An overview of who owns the company. Click on chart icon to view historical movement.
LYKALABS Bulk, Block & Insider Trades
LYKALABS Dividends, Splits & Bonus
Dividend Events
Capital Change Events
Rights issue
Rights issue(1 new shares @ 30 INR for 2 existing shares) Ex-date: 22nd Oct 1993
Company Profile
Lyka Labs Limited is an India-based pharmaceutical company engaged in the development, manufacture and marketing of quality finished dosages. The Company manufactures pharmaceutical products such as Dry Powder, Liquid, Lyophilized Injections and External Preparations for several International Market... Read More
Key personnel
Mr. Babulal JainD
Independent Chairman of the Board
Mr. Kunal Narendra GandhiD
Chief Executive Officer, Managing Director, Executive Director
Mr. Yogesh B. ShahD
Chief Financial Officer, Whole-Time Director
Mr. Prashant GodhaD
Additional Director
Mr. Shashil MendonsaD
Additional Director
Shri. Vinod S. ShanbhagD
Additional Independent Director
Mr. Neeraj GolasD
Additional Non-Executive Independent Director
Ms. Archana YadavD
Additional Non-Executive Independent Women Director
View all
Incorporated on
Last Annual
Last Interim
No. of Employees
IPO date
Free Float
Website
Phone no.
Address
Frequently asked questions
What is the current share price of Lyka Labs Ltd.?
The current share price of Lyka Labs Ltd. is ₹ 79.08 as of 09 Jan 2026.
What is the PE ratio of Lyka Labs Ltd.?
The Price-to-Earnings (PE) ratio of Lyka Labs Ltd. is 128.40 as of the latest financial data.
What is the ROE and ROCE of Lyka Labs Ltd.?
Lyka Labs Ltd. has a Return on Equity (ROE) of 3.27% and a Return on Capital Employed (ROCE) of 107.28% as per the latest financial reports.
What is the market cap of Lyka Labs Ltd.?
The market capitalization of Lyka Labs Ltd. stands at ₹ 282.24 Cr.
What is the dividend yield of Lyka Labs Ltd.?
The dividend yield of Lyka Labs Ltd. is 0.00% based on the current market price.
What is the RSI of Lyka Labs Ltd.?
The Relative Strength Index (RSI) of Lyka Labs Ltd. is 49.43.
What is the FII and DII holding in Lyka Labs Ltd.?
Foreign Institutional Investors (FII) hold 0.17% and Domestic Institutional Investors (DII) hold 0.29% of Lyka Labs Ltd. shares.
What sector does Lyka Labs Ltd. belong to?
Lyka Labs Ltd. operates in the Healthcare sector.
What is the beta of Lyka Labs Ltd. stock?
The beta of Lyka Labs Ltd. stock is 0.94, indicating its volatility relative to the broader market.
